| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/15/2010 | US20100178272 Structure and use of 5'phosphate oligonucleotides |
| 07/15/2010 | US20100178271 Combination Therapy |
| 07/15/2010 | US20100178247 Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer |
| 07/15/2010 | US20100178246 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma |
| 07/15/2010 | US20100178245 Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites |
| 07/15/2010 | US20100178244 Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites |
| 07/15/2010 | US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/15/2010 | DE102009004061A1 Pyridazinonderivate Pyridazinone derivatives |
| 07/15/2010 | DE102007042107B4 Pharmazeutische Zusammensetzung mit eisenbindendem Agens A pharmaceutical composition comprising eisenbindendem agent |
| 07/15/2010 | CA2749575A1 Compounds and uses thereof for treating inflammation and modulating immune responses |
| 07/15/2010 | CA2749339A1 Modified antibody compositions, methods of making and using thereof |
| 07/15/2010 | CA2749261A1 Combination therapies for neoplastic disorders |
| 07/15/2010 | CA2749015A1 Pyridazinone derivatives |
| 07/15/2010 | CA2749012A1 Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof |
| 07/15/2010 | CA2748911A1 Pyridazinone derivatives |
| 07/15/2010 | CA2748908A1 Benzothiazolone derivatives |
| 07/15/2010 | CA2748291A1 Cancer treatment |
| 07/15/2010 | CA2748181A1 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders |
| 07/15/2010 | CA2747437A1 Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-a zetidine-3-carboxylic acid |
| 07/15/2010 | CA2747192A1 Compositions and methods to prevent cancer with cupredoxins |
| 07/15/2010 | CA2747154A1 Immunocytokines for tumour therapy with chemotherapeutic agents |
| 07/15/2010 | CA2747011A1 Nkg2d-fc for immunotherapy |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2206719A2 Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens: Synthesis, In Vitro Biological Activities, Pharmacokinetics and Antitumor |
| 07/14/2010 | EP2206713A1 Beta-carbolines useful for treating inflammatory disease |
| 07/14/2010 | EP2206534A1 Dibenzocycloheptanone derivatives und pharmaceutical agents containing these compounds |
| 07/14/2010 | EP2206517A1 Immunopotentiating compositions comprising anti-PD-L1 antibodies |
| 07/14/2010 | EP2206511A1 Protein a compositions and methods of use |
| 07/14/2010 | EP2206502A1 Polymer conjugate of steroid |
| 07/14/2010 | EP2206501A2 HMGA binding nucleic acids |
| 07/14/2010 | EP2205640A2 Antibodies that bind il-4 and/or il-13 and their uses |
| 07/14/2010 | EP2205634A2 Anti-neublastin antibodies and uses thereof |
| 07/14/2010 | EP2205616A1 Novel sulfated oligosaccharide derivatives |
| 07/14/2010 | EP2205610A1 Thienopyrimidiene derivatives as pi3k inhibitors |
| 07/14/2010 | EP2205605A1 Hydrated crystalline esters of camptothecin for the treatment of cancer |
| 07/14/2010 | EP2205603A1 Pyrimidine derivatives as protein kinase inhibitors |
| 07/14/2010 | EP2205592A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/14/2010 | EP2205568A1 6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors |
| 07/14/2010 | EP2205563A2 Novel histone deacetylase inhibitors |
| 07/14/2010 | EP2205268A1 Interferon alpha sequential regimen for treating cancers |
| 07/14/2010 | EP2205257A2 Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| 07/14/2010 | EP2205244A1 Methods of administering n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-ý7-(2-morpholin-4-yl-ethoxy)imidazoý2,1-b¨ý1,3¨benzothiazol-2-yl¨phenyl}urea to treat proliferative disease |
| 07/14/2010 | EP2205242A2 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use |
| 07/14/2010 | EP2205239A2 Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies |
| 07/14/2010 | EP2205237A1 Methods for protecting the skin from radiation insults |
| 07/14/2010 | EP2205236A2 Novel agents for treatment of ailments and dysfunctions |
| 07/14/2010 | EP2205215A2 Docetaxel injectable composition, being absolutely free of ethanol |
| 07/14/2010 | EP2205077A1 Therapies for treating cancer using combinations of cox-2 inhibitors and anti-her2(erbb2) antibodies or combinations of cox-2 inhibitors and her2(erbb2) receptor tyrosine kinase inhibitors |
| 07/14/2010 | EP2205076A1 Combination therapy for the treatment of cancer using cox-2 inhibitors and dual inhibitors of egfr ýerbb1¨and her-2 ýerbb2¨ |
| 07/14/2010 | EP2205075A1 Therapies for treating cancer using combinations of cox-2 inhibitors and aromatase inhibitors or combinations of cox-2 inhibitors and estrogen receptor antagonists |
| 07/14/2010 | EP2205073A1 Azacytidine analogues and uses thereof |
| 07/14/2010 | EP2205069A1 Combretum laurifolium mart. extract and methods of extracting and using such extract |
| 07/14/2010 | EP1863530B1 Methods for damaging cells using effector functions of anti-gfra1 antibodies |
| 07/14/2010 | EP1853602B1 Chemical compounds |
| 07/14/2010 | EP1734995B1 Monoclonal antibodies to hepatocyte growth factor |
| 07/14/2010 | EP1723138B1 Substituted benzimidazoles and their use for inducing apoptosis |
| 07/14/2010 | EP1514116B9 Oxaliplatin anti-resistance method |
| 07/14/2010 | EP1513859B1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 07/14/2010 | EP1486494B1 N-substituted benzothiophenesulfonamide derivative |
| 07/14/2010 | EP1383551B1 Multilumen catheter and implants for the delivery of therapeutic agents to tissues |
| 07/14/2010 | EP1222226B1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 07/14/2010 | EP1220684B2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/14/2010 | CN1980933B Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
| 07/14/2010 | CN1813967B Chinese medicine remedy for treating cancer of alimentany tract |
| 07/14/2010 | CN101778867A Compositions and methods for treating pancreatic tumors |
| 07/14/2010 | CN101778857A platinum (iv) complexes |
| 07/14/2010 | CN101778851A Fused bicyclic pyrimidines |
| 07/14/2010 | CN101778839A substituted hydantoins |
| 07/14/2010 | CN101778641A Preventive/remedy for cancer |
| 07/14/2010 | CN101778639A Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
| 07/14/2010 | CN101778633A Weekly administration of dipeptidyl peptidase inhibitors |
| 07/14/2010 | CN101778627A Multikinase inhibitors for use in the treatment of cancer |
| 07/14/2010 | CN101775401A Rana chensinensis functional gene Rd-RNase3 sequence, construction method and amino acid sequence and application thereof |
| 07/14/2010 | CN101775400A Rana chensinensis functional gene Rd-RNase2 sequence, construction method and amino acid sequence and application thereof |
| 07/14/2010 | CN101775395A Construction of siRNA recombinants 191 by aiming at CDK2 genes and application |
| 07/14/2010 | CN101775394A Construction of siRNA recombinants 190 by aiming at CDK2 genes and application |
| 07/14/2010 | CN101775393A Construction of siRNA recombinants 189 by aiming at CDK2 genes and application |
| 07/14/2010 | CN101775392A Construction of siRNA recombinants 188 by aiming at CDK2 genes and application |
| 07/14/2010 | CN101775391A Construction of siRNA recombinants 187 by aiming at CDK2 genes and application |
| 07/14/2010 | CN101775390A Construction of siRNA recombinants 186 by aiming at CDK2 genes and application |
| 07/14/2010 | CN101775375A Preparation method of recombinant adeno-associated viruses containing EB virus latent membrane protein 1 and 2 genes and application thereof |
| 07/14/2010 | CN101775145A Quaternary grating material and preparation method and application thereof |
| 07/14/2010 | CN101775078A Sea urchin content polysaccharide having anti-tumor and immunological activities and preparation method |
| 07/14/2010 | CN101775073A Drug for inhibiting proliferation of tumor cells and application thereof |
| 07/14/2010 | CN101775059A Novel glycyrrhetinic acid derivative, and preparation method and medicinal uses thereof |
| 07/14/2010 | CN101775032A Niclosamide phosphate ester and pharmaceutically acceptable salt and application thereof |
| 07/14/2010 | CN101775019A Melotenine and pharmaceutical composition as well as preparation method and application thereof |
| 07/14/2010 | CN101774993A Chrysin nitrogen-containing derivative as well as preparation method and purpose thereof |
| 07/14/2010 | CN101774976A Sulfonyl isoxazoline derivative and anti-tumor application |
| 07/14/2010 | CN101774959A Preparation method and application of bromine-containing indole alkaloid |
| 07/14/2010 | CN101774891A Method for preparing diterpene compound and application thereof |
| 07/14/2010 | CN101773671A Application of shRNA (short hairpin Ribonucleic Acid) of Periostin gene in preparing medicament for inhibiting tumor |
| 07/14/2010 | CN101773666A Therapeutic anticancer vaccine and preparation thereof |
| 07/14/2010 | CN101773659A Chinese medicine composition for treating esophageal cancer and preparation method thereof |
| 07/14/2010 | CN101773648A Chinese medicine composition for treating gastric cancer and preparation method thereof |
| 07/14/2010 | CN101773647A Chinese medicine composition for treating duodenal carcinoma and preparation method thereof |
| 07/14/2010 | CN101773636A Antitumor nanometer Chinese medicine and production method thereof |
| 07/14/2010 | CN101773625A Anticancerogen, preparation method and application thereof |
| 07/14/2010 | CN101773623A Eight-in-one anti-tumor nano traditional Chinese medicine and production method thereof |
| 07/14/2010 | CN101773556A Anti-tumor five-in-one nano-TCM and production method thereof |